Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05968898 · ClinicalTrials.gov registry record · NA
Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES
A NA study of Lung Cancer and Pulmonary Nodule, Solitary, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT05968898 is a NA study of Lung Cancer and Pulmonary Nodule, Solitary that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 300 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (68% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT05968898, a NA study of Lung Cancer and Pulmonary Nodule, Solitary, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a pragmatic clinical trial that will study the effect of a radiomics-based computer-aided diagnosis (CAD) tool on clinicians' management of pulmonary nodules (PNs) compared to usual care. Adults aged 35-89 years with 8-30mm PNs evaluated at Penn Medicine PN clinics will undergo 1:1 randomization to one of two groups, defined by the PN malignancy risk stratification strategy used by evaluating clinicians: 1) usual care or 2) usual care + use of a radiomics-based CAD tool.
Conditions Studied
Interventions
- DEVICE Optellum Virtual Nodule Clinic
Study Locations (3)
Pennsylvania
- Penn Medicine University City - Philadelphia
- Perelman Center for Advanced Medicine - Philadelphia
- Penn Medicine Washington Square - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-01-09 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05968898
The ClinicalTrials.gov registry entry for NCT05968898 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (68% lower). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Optellum Virtual Nodule Clinic is the first listed.
NCT05968898 reports 3 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05968898 about?
NCT05968898 is a clinical study titled "Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES". This is a pragmatic clinical trial that will study the effect of a radiomics-based computer-aided diagnosis (CAD) tool on clinicians' management of pulmonary nodules (PNs) compared to usual care. Adults aged 35-89 years with 8-30mm PNs evaluated at Penn Medicine PN clinics will undergo 1:1 randomiza...
What is the current status of trial NCT05968898?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-01-09. Estimated completion is 2027-12-31.
What conditions does trial NCT05968898 study?
This clinical trial studies the following conditions: Lung Cancer, Pulmonary Nodule, Solitary.
What interventions are being tested in trial NCT05968898?
The interventions under investigation include: Optellum Virtual Nodule Clinic (DEVICE).
Who is sponsoring clinical trial NCT05968898?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05968898 being conducted?
This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.